Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
about
5-alpha-reductase inhibitors for prostate cancer preventionScreening for prostate cancerScreening for prostate cancerFinasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Long-term survival of participants in the prostate cancer prevention trial.Chemoprevention of prostate cancer.Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention TrialPrevention of prostate cancer: outcomes of clinical trials and future opportunities.Extracting the Benefit of Nexrutine® for Cancer Prevention.Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.Current status of 5α-reductase inhibitors in prostate disease managementDoes the level of prostate cancer risk affect cancer prevention with finasteride?The intriguing role of fibroblasts and c-Jun in the chemopreventive and therapeutic effect of finasteride on xenograft models of prostate cancer.Prevention of prostate cancer: what we know and where we are going.Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionShould prostate-specific antigen screening be offered to asymptomatic men?The implementation of screening for prostate cancer.Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.Prostate Cancer Prevention: Do the 5-ARIs Make the Grade?
P2860
Q22252970-37019E2D-2E1D-4FB5-A00E-78BCB1E6A859Q24201690-8D095A55-7164-489B-A286-AAD250BB3886Q24245476-7526BD0C-5A79-4BDE-BE86-C6F97EC82C13Q33750580-86387B2D-F8F5-4902-8DBC-F52A91F106F0Q33882778-55647CCB-6BB5-4835-BB47-3C24C9B4D63BQ33894354-6D87F952-193B-4E17-9A9D-04B753082246Q34005866-5966ABBB-E219-48B1-9665-292894EE50F7Q34020127-5A3B90D2-5352-4FBC-88D4-059A931E2F28Q34077860-B7C07CE7-F0A6-4139-8DE0-17F91E1BE963Q34186757-EA1881C9-D3D8-4D02-AB98-2B414F16D86DQ34756869-F7E378EE-25E0-46FC-8CA9-92CDAD54F981Q35067699-107C3E5D-EA07-44B1-877A-45183DBCDC0CQ36236997-0CD927E7-86AA-47DA-B5C2-BF83FEDFC80DQ36306367-125ADB77-5F0A-4952-9256-64FE5D14DF96Q36778346-A3B66DB8-F7B0-4B80-9251-DD2ADCD01FF9Q37217579-CEE17740-EBC6-4A67-9319-1F52B86EEA81Q37414987-EE2E14F0-0C2F-45D4-9925-4021A438E9F8Q37499593-4C8C7949-A9BD-4D09-BE02-DDE1D9098088Q37700962-08CC3544-6AA5-4032-8687-1CDF218A9E4EQ37774352-75345D69-856A-4B24-AB90-A39678314D19Q37777325-1893DC63-2A52-4DBD-8C01-52CE031B037AQ46200270-13D66BCB-5DA9-4CBD-929D-539A4DEA0DF7Q57989222-F82A0A16-D072-48B3-95F2-D13E04650FC7
P2860
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Finasteride improves the sensi ...... for prostate cancer detection.
@en
Finasteride improves the sensi ...... for prostate cancer detection.
@nl
type
label
Finasteride improves the sensi ...... for prostate cancer detection.
@en
Finasteride improves the sensi ...... for prostate cancer detection.
@nl
prefLabel
Finasteride improves the sensi ...... for prostate cancer detection.
@en
Finasteride improves the sensi ...... for prostate cancer detection.
@nl
P2093
P1476
Finasteride improves the sensi ...... for prostate cancer detection.
@en
P2093
Catherine M Tangen
Charles A Coltman
Howard L Parnes
Ian M Thompson
M Scott Lucia
Phyllis J Goodman
Scott M Lippman
P304
P356
10.1016/J.JURO.2007.01.071
P407
P577
2007-05-01T00:00:00Z